Literature DB >> 2442337

Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection.

T J Conboy, R F Pass, S Stagno, C A Alford, G J Myers, W J Britt, F P McCollister, M N Summers, C E McFarland, T J Boll.   

Abstract

The Developmental Profile was completed on 32 prospectively followed children with symptomatic congenital cytomegalovirus infection (mean age 6 7/12 years; 78% white, 59% male). The distribution of intelligence and general developmental scores was bimodal; one group had severe deficits (mean IQ 28.8), the other had relatively less severe intellectual sequelae (mean IQ 91.6). Correlation analysis (Pearson r) showed that three variables--microcephaly, neurologic abnormalities, and chorioretinitis--when apparent during the first year of life, were all significantly associated with low intelligence. No correlation was found between IQ and severity of neonatal reticuloendothelial disease or hearing loss. Multiple regression analysis showed that age at testing, chorioretinitis, and neurologic sequelae accounted for 63% of the IQ variance in our sample. We conclude that children with symptomatic congenital cytomegalovirus infection have a greater range of intellectual outcomes than has been previously reported, and that certain early clinical manifestations may be useful in anticipating special needs.

Entities:  

Mesh:

Year:  1987        PMID: 2442337     DOI: 10.1016/s0022-3476(87)80451-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  27 in total

1.  Congenital cytomegalovirus infection - An update.

Authors:  S Friedman; E L Ford-Jones
Journal:  Paediatr Child Health       Date:  1999-01       Impact factor: 2.253

Review 2.  Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat?

Authors:  Richard J Whitley
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

Review 3.  The use of antiviral drugs during the neonatal period.

Authors:  Richard J Whitley
Journal:  Clin Perinatol       Date:  2012-01-21       Impact factor: 3.430

4.  Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection.

Authors:  A Mackenzie Dreher; Nitin Arora; Karen B Fowler; Zdenek Novak; William J Britt; Suresh B Boppana; Shannon A Ross
Journal:  J Pediatr       Date:  2014-01-14       Impact factor: 4.406

5.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.

Authors:  A Maeda; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Clinical Predictors of Sensorineural Hearing Loss and Cognitive Outcome in Infants with Symptomatic Congenital Cytomegalovirus Infection.

Authors:  Swetha G Pinninti; Mackenzie D Rodgers; Zdenek Novak; William J Britt; Karen B Fowler; Suresh B Boppana; Shannon A Ross
Journal:  Pediatr Infect Dis J       Date:  2016-08       Impact factor: 2.129

Review 7.  Congenital cytomegalovirus infection: new prospects for prevention and therapy.

Authors:  Elizabeth C Swanson; Mark R Schleiss
Journal:  Pediatr Clin North Am       Date:  2013-04       Impact factor: 3.278

8.  Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.

Authors:  Sara E Oliver; Gretchen A Cloud; Pablo J Sánchez; Gail J Demmler; Wayne Dankner; Mark Shelton; Richard F Jacobs; Wendy Vaudry; Robert F Pass; Seng-jaw Soong; Richard J Whitley; David W Kimberlin
Journal:  J Clin Virol       Date:  2009-09-18       Impact factor: 3.168

9.  Outcome of confirmed symptomatic congenital cytomegalovirus infection.

Authors:  M E Ramsay; E Miller; C S Peckham
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

10.  Trends in hospitalizations for diagnosed congenital cytomegalovirus in infants and children in Australia.

Authors:  Holly Seale; Robert Booy; C Raina MacIntyre
Journal:  BMC Pediatr       Date:  2009-01-26       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.